“…We additionally excluded participants I) that were taking psychoactive drugs (urine drug screening and semi-structured interview for, buprenorphine, amphetamine, benzodiazepine, cocaine, methamphetamine, morphine/heroine, methadone, and marihuana; n=19), 2) with neurological disorders (DSM-5 diagnosis; n=28) and/or alcohol abuse and family history of alcohol addiction (DSM-5 diagnosis and semi-structured interview; n=53), 3) with failed spatial normalization as identified by visual inspection (n=2), and, 4) with missing demographic and/or MRI data (n=8). After applying these criteria a total of 133 participants remained, in line with previous studies (Doucet et al, 2021), both dataset subjects were subdivided into two distinct participant groups (young: n=88, age-range = 20-35, male/female=57/31; older: n=45, age-range=55-80, male/female = 22/23). All participants provided written informed consent.…”